Naji Marshall: Everything you need to know

Naji Marshall

#13 SF

Dallas Mavericks

Status

OUT - Hip - Bruise Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

10.1

4.0

2.5

0.2

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	74	47	29.5	15.2	4.7	3.3	0.1	1.1	1.6	2	0.8	2.9	29.1%	4.8	8.2	58.7%	5.7	11.1	51.0%	3.1	4.1	76.0%	0.9	3.8	1.9	2.0	-218	59.2%
2024-25	69	31	27.8	13.2	4.8	3.0	0.2	1.0	1.6	6	0.9	3.2	27.5%	4.4	7.2	61.1%	5.2	10.3	50.8%	1.9	2.3	81.3%	1.1	3.7	1.6	1.9	-137	58.4%
2023-24	66	1	19.0	7.1	3.6	1.9	0.2	0.7	1.0	0	0.9	2.3	38.7%	1.7	3.3	51.6%	2.6	5.6	46.3%	1.0	1.3	79.1%	0.8	2.8	1.4	2.0	+205	57.6%
2022-23	77	21	23.3	9.1	3.6	2.5	0.2	0.7	1.3	0	0.9	2.8	30.3%	2.4	4.6	51.3%	3.2	7.4	43.3%	1.8	2.3	78.9%	0.6	3.0	1.5	1.9	+6	53.9%
2021-22	55	4	13.4	5.7	2.6	1.1	0.1	0.6	0.8	1	0.4	1.9	20.0%	1.6	3.0	53.7%	2.0	4.9	40.5%	1.3	1.7	79.6%	0.7	1.9	1.3	1.3	-49	50.5%
2020-21	32	10	21.9	7.7	4.6	2.8	0.3	0.8	1.2	3	0.9	2.6	34.9%	1.7	3.9	42.1%	2.6	6.5	39.2%	1.7	2.3	70.7%	0.5	4.2	1.8	2.3	-28	50.8%
Career	373	114	23.0	10.1	4.0	2.5	0.2	0.8	1.3	12	0.8	2.6	30.0%	2.9	5.3	55.7%	3.7	7.9	47.1%	1.9	2.4	77.7%	0.8	3.2	1.6	1.9	-221	56.4%

Career Averages

PTS

REB

AST

BLK

STL

5.4

1.7

1.0

0.3

Year	GP	MIN	PTS	REB	AST	BLK	STL	TO	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2023-24	4	21.0	9.0	2.8	1.3	0.5	0.5	0.5	1.5	3.8	40.0%	1.5	3.3	46.2%	3.0	7.0	42.9%	1.5	1.5	100.0%	0.8	2.0	2.3	2.5	-31	58.7%
2021-22	6	9.3	3.0	1.0	0.8	0.2	0.2	0.5	0.0	0.0	0.0%	1.2	1.7	70.0%	1.2	1.7	70.0%	0.7	0.7	100.0%	0.5	0.5	0.8	1.7	+0	76.5%
Career	10	14.0	5.4	1.7	1.0	0.3	0.3	0.5	0.6	1.5	40.0%	1.3	2.3	56.5%	1.9	3.8	50.0%	1.0	1.0	100.0%	0.6	1.1	1.4	2.0	-31	63.7%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/15	LAL	W 121-94	21	6	3	2	0	0	1	2	0	0.0%	6	3	50.0%	8	3	37.5%	0	0	0.0%	0	3	2.0	+7	1	3	37.5%
10/13	UTA	W 114-101	21	17	2	1	1	0	1	3	1	33.3%	4	3	75.0%	7	4	57.1%	10	8	80.0%	1	1	1.0	+15	2	18	74.6%
10/11	CHA	L 120-116	18	13	3	4	0	3	3	1	1	100.0%	7	4	57.1%	8	5	62.5%	4	2	50.0%	1	2	1.3	+5	2	15	66.6%
10/6	OKC	W 106-89	14	2	3	2	0	0	2	1	0	0.0%	2	0	0.0%	3	0	0.0%	2	2	100.0%	0	3	1.0	+16	2	1	25.8%
Preseason Totals			19.2	9.5	2.8	2.3	0.3	0.8	1.8	1.8	0.5	28.6%	4.8	2.5	52.6%	6.5	3.0	46.2%	4.0	3.0	75.0%	0.5	2.3	1.3	+43	1.8	11.8	57.5%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/7	LAC	L 116-103	19	6	2	0	0	3	1	1	0	0.0%	9	3	33.3%	10	3	30.0%	0	0	0.0%	0	2	0.0	-13	3	0	30.0%
4/5	LAL	W 134-128	31	13	6	7	0	2	2	2	0	0.0%	7	5	71.4%	9	5	55.6%	6	3	50.0%	0	6	3.5	-5	2	20	55.8%
4/3	ORL	L 138-127	23	9	4	2	0	1	0	3	1	33.3%	9	2	22.2%	12	3	25.0%	2	2	100.0%	1	3	0.0	-16	2	4	34.9%
3/27	POR	W 100-93	32	19	3	3	0	5	1	2	0	0.0%	12	7	58.3%	14	7	50.0%	7	5	71.4%	0	3	3.0	+7	3	21	55.6%
3/25	DEN	L 142-135	29	22	4	3	0	0	1	6	1	16.7%	11	6	54.5%	17	7	41.2%	8	7	87.5%	0	4	3.0	-7	2	20	53.6%
3/23	GSW	L 137-131	35	16	6	7	0	1	8	6	2	33.3%	9	5	55.6%	15	7	46.7%	0	0	0.0%	1	5	0.9	+3	2	13	53.3%
3/21	LAC	L 138-131	37	28	2	4	0	2	2	6	1	16.7%	17	10	58.8%	23	11	47.8%	7	5	71.4%	1	1	2.0	-19	2	21	53.7%
3/18	ATL	L 135-120	28	4	3	4	0	1	1	1	0	0.0%	9	2	22.2%	10	2	20.0%	0	0	0.0%	0	3	4.0	-7	1	2	20.0%
3/16	NOP	L 129-111	32	32	8	7	0	0	0	4	2	50.0%	20	10	50.0%	24	12	50.0%	8	6	75.0%	3	5	0.0	-6	3	31	58.1%
3/15	CLE	W 130-120	32	25	5	7	0	1	3	1	1	100.0%	11	7	63.6%	12	8	66.7%	8	8	100.0%	2	3	2.3	+10	1	34	80.5%
3/13	CLE	L 138-105	26	17	7	3	0	1	2	4	2	50.0%	8	5	62.5%	12	7	58.3%	4	1	25.0%	3	4	1.5	-17	0	19	61.8%
3/12	MEM	W 120-112	23	5	6	3	0	1	6	3	0	0.0%	4	2	50.0%	7	2	28.6%	2	1	50.0%	0	6	0.5	-1	1	2	31.7%
3/10	ATL	L 124-112	29	14	2	4	0	1	3	5	2	40.0%	4	3	75.0%	9	5	55.6%	2	2	100.0%	1	1	1.3	-18	3	14	70.9%
3/8	TOR	L 122-92	21	8	0	1	0	0	1	0	0	0.0%	5	3	60.0%	5	3	60.0%	2	2	100.0%	0	0	1.0	-4	2	5	68.0%
3/6	BOS	L 120-100	25	13	1	3	0	0	1	1	1	100.0%	11	5	45.5%	12	6	50.0%	0	0	0.0%	1	0	3.0	-20	3	5	54.2%
3/5	ORL	L 115-114	25	6	4	5	0	2	2	2	0	0.0%	8	2	25.0%	10	2	20.0%	2	2	100.0%	2	2	2.5	-6	2	6	27.6%
2/27	MEM	L 124-105	23	4	2	2	1	1	3	1	0	0.0%	5	2	40.0%	6	2	33.3%	0	0	0.0%	0	2	0.7	-24	1	2	33.3%
2/26	SAC	L 130-121	42	36	10	6	0	0	3	4	1	25.0%	19	13	68.4%	23	14	60.9%	11	7	63.6%	1	9	2.0	+3	2	39	64.7%
2/24	BKN	W 123-114	36	21	5	7	0	1	1	0	0	0.0%	13	7	53.8%	13	7	53.8%	9	7	77.8%	1	4	7.0	+12	1	29	61.9%
2/22	IND	W 134-130	25	17	2	2	0	1	2	1	0	0.0%	9	7	77.8%	10	7	70.0%	6	3	50.0%	1	1	1.0	-1	2	15	67.2%
2/20	MIN	L 122-111	33	15	5	3	0	3	3	4	0	0.0%	12	5	41.7%	16	5	31.3%	7	5	71.4%	0	5	1.0	+1	2	12	39.3%
2/12	LAL	L 124-104	29	19	2	4	0	2	2	3	0	0.0%	10	8	80.0%	13	8	61.5%	5	3	60.0%	0	2	2.0	-2	2	19	62.5%
2/10	PHX	L 120-111	36	31	4	2	0	1	2	4	2	50.0%	13	10	76.9%	17	12	70.6%	7	5	71.4%	1	3	1.0	+5	0	33	77.2%
2/7	SAS	L 138-125	25	6	3	5	0	3	1	2	0	0.0%	6	1	16.7%	8	1	12.5%	4	4	100.0%	0	3	5.0	-8	2	9	30.7%
2/5	SAS	L 135-123	38	32	6	3	0	0	1	7	4	57.1%	14	8	57.1%	21	12	57.1%	4	4	100.0%	1	5	3.0	+5	2	31	70.3%
2/3	BOS	L 110-100	31	9	8	3	0	0	1	5	1	20.0%	10	3	30.0%	15	4	26.7%	0	0	0.0%	2	6	3.0	-13	1	4	30.0%
1/31	HOU	L 111-107	31	8	8	2	0	0	0	1	0	0.0%	10	3	30.0%	11	3	27.3%	6	2	33.3%	1	7	0.0	-18	1	7	29.3%
1/28	MIN	L 118-105	32	18	6	1	1	0	2	0	0	0.0%	14	7	50.0%	14	7	50.0%	5	4	80.0%	2	4	0.5	+1	3	16	55.6%
1/24	LAL	L 116-110	36	21	11	2	0	1	3	3	0	0.0%	12	7	58.3%	15	7	46.7%	10	7	70.0%	4	7	0.7	-8	3	23	54.1%
1/22	GSW	W 123-115	33	30	7	9	0	0	4	3	2	66.7%	9	8	88.9%	12	10	83.3%	8	8	100.0%	0	7	2.3	+17	2	41	96.6%
1/19	NYK	W 114-97	33	19	8	4	0	1	1	6	1	16.7%	12	6	50.0%	18	7	38.9%	4	4	100.0%	0	8	4.0	+15	1	21	48.1%
1/17	UTA	W 138-120	29	16	5	6	0	1	3	2	1	50.0%	8	6	75.0%	10	7	70.0%	3	1	33.3%	0	5	2.0	+26	4	18	70.7%
1/15	UTA	W 144-122	23	22	6	4	0	3	1	4	2	50.0%	11	7	63.6%	15	9	60.0%	2	2	100.0%	1	5	4.0	+16	1	28	69.3%
1/14	DEN	L 118-109	38	24	5	3	0	0	3	3	0	0.0%	13	9	69.2%	16	9	56.3%	8	6	75.0%	1	4	1.0	-3	2	24	61.5%
1/12	BKN	W 113-105	32	22	4	9	1	3	2	1	0	0.0%	13	9	69.2%	14	9	64.3%	4	4	100.0%	3	1	4.5	+12	0	33	69.8%
1/10	CHI	L 125-107	24	14	4	3	0	3	0	4	1	25.0%	7	3	42.9%	11	4	36.4%	8	5	62.5%	0	4	0.0	-10	1	16	48.2%
1/8	UTA	L 116-114	36	17	2	4	0	0	1	5	2	40.0%	6	5	83.3%	11	7	63.6%	2	1	50.0%	0	2	4.0	-9	1	16	71.5%
1/6	SAC	W 100-98	31	15	7	1	0	2	4	2	1	50.0%	8	6	75.0%	10	7	70.0%	2	0	0.0%	2	5	0.3	-3	2	15	68.9%
1/3	HOU	W 110-104	33	10	2	5	0	0	1	3	0	0.0%	8	5	62.5%	11	5	45.5%	1	0	0.0%	0	2	5.0	+4	2	9	43.7%
1/1	PHI	L 123-108	22	9	1	1	0	0	0	0	0	0.0%	7	4	57.1%	7	4	57.1%	1	1	100.0%	0	1	0.0	+2	0	10	60.5%
12/29	POR	L 125-122	29	17	7	4	0	0	2	3	1	33.3%	9	6	66.7%	12	7	58.3%	3	2	66.7%	1	6	2.0	+3	3	19	63.8%
12/27	SAC	L 113-107	26	11	2	1	0	1	2	1	1	100.0%	8	3	37.5%	9	4	44.4%	4	2	50.0%	0	2	0.5	-1	2	5	51.1%
12/25	GSW	L 126-116	27	14	4	0	0	0	1	2	0	0.0%	12	5	41.7%	14	5	35.7%	4	4	100.0%	0	4	0.0	-3	3	7	44.4%
12/23	DEN	W 131-130	31	15	4	3	0	1	1	4	2	50.0%	7	4	57.1%	11	6	54.5%	1	1	100.0%	1	3	3.0	-12	0	18	65.6%
12/22	NOP	L 119-113	29	15	5	6	0	0	1	2	1	50.0%	8	6	75.0%	10	7	70.0%	0	0	0.0%	1	4	6.0	-6	2	20	75.0%
12/20	PHI	L 121-114	34	22	9	4	0	2	5	0	0	0.0%	12	9	75.0%	12	9	75.0%	4	4	100.0%	2	7	0.8	+16	3	28	79.9%
12/18	DET	W 116-114	33	16	3	1	0	0	0	3	0	0.0%	6	5	83.3%	9	5	55.6%	7	6	85.7%	0	3	0.0	+16	4	15	66.2%
12/15	UTA	L 140-133	36	15	3	1	0	1	0	3	1	33.3%	9	6	66.7%	12	7	58.3%	0	0	0.0%	0	3	0.0	-5	1	15	62.5%
12/12	BKN	W 119-111	32	17	1	4	0	1	1	3	1	33.3%	6	5	83.3%	9	6	66.7%	5	4	80.0%	1	0	4.0	-4	3	18	75.9%
12/6	HOU	W 122-109	28	15	2	2	0	1	1	3	1	33.3%	5	5	100.0%	8	6	75.0%	2	2	100.0%	1	1	2.0	+5	1	18	84.5%
12/5	OKC	L 132-111	26	18	1	2	0	1	0	2	0	0.0%	9	8	88.9%	11	8	72.7%	4	2	50.0%	0	1	0.0	-24	3	17	70.5%
12/3	MIA	W 118-108	35	18	5	4	1	2	0	4	2	50.0%	8	6	75.0%	12	8	66.7%	0	0	0.0%	3	2	0.0	+10	4	21	75.0%
12/1	DEN	W 131-121	32	9	7	6	0	0	3	3	1	33.3%	4	3	75.0%	7	4	57.1%	0	0	0.0%	2	5	2.0	-5	3	12	64.3%
11/29	LAC	W 114-110	36	18	8	3	0	3	0	6	2	33.3%	5	4	80.0%	11	6	54.5%	4	4	100.0%	1	7	0.0	+13	3	26	70.5%
11/28	LAL	L 129-119	24	16	7	2	0	1	1	2	1	50.0%	6	3	50.0%	8	4	50.0%	7	7	100.0%	3	4	2.0	-7	4	21	72.2%
11/24	MIA	L 106-102	21	7	5	0	0	2	2	4	1	25.0%	3	2	66.7%	7	3	42.9%	1	0	0.0%	1	4	0.0	-15	1	6	47.0%
11/22	MEM	L 102-96	29	13	7	4	2	0	0	4	1	25.0%	4	3	75.0%	8	4	50.0%	4	4	100.0%	0	7	0.0	-2	1	22	66.6%
11/21	NOP	W 118-115	23	9	5	5	0	0	2	3	1	33.3%	2	1	50.0%	5	2	40.0%	6	4	66.7%	0	5	2.5	+5	1	14	58.9%
11/19	NYK	L 113-111	33	23	5	1	0	0	4	5	3	60.0%	6	4	66.7%	11	7	63.6%	7	6	85.7%	0	5	0.3	-11	0	24	81.7%
11/17	MIN	L 120-96	23	7	3	0	0	1	2	3	0	0.0%	6	3	50.0%	9	3	33.3%	3	1	33.3%	0	3	0.0	-24	0	1	33.9%
11/16	POR	W 138-133	27	9	9	3	0	2	2	2	0	0.0%	4	3	75.0%	6	3	50.0%	6	3	50.0%	3	6	1.5	-8	1	17	52.1%
11/14	LAC	L 133-127	47	28	8	2	0	1	0	5	3	60.0%	14	5	35.7%	19	8	42.1%	10	9	90.0%	2	6	0.0	-1	4	27	59.8%
11/12	PHX	L 123-114	26	12	4	3	0	1	2	3	2	66.7%	3	2	66.7%	6	4	66.7%	2	2	100.0%	0	4	1.5	-23	2	14	87.2%
11/10	MIL	L 116-114	25	9	5	3	0	1	1	4	0	0.0%	4	4	100.0%	8	4	50.0%	2	1	50.0%	0	5	3.0	+7	2	11	50.7%
11/8	WAS	W 111-105	31	30	8	2	0	3	0	4	3	75.0%	10	6	60.0%	14	9	64.3%	11	9	81.8%	3	5	0.0	+6	2	38	79.6%
11/7	MEM	L 118-104	25	16	7	4	0	1	1	7	1	14.3%	6	5	83.3%	13	6	46.2%	4	3	75.0%	0	7	4.0	+6	1	20	54.2%
11/5	NOP	L 101-99	25	7	5	5	0	1	1	2	0	0.0%	3	2	66.7%	5	2	40.0%	4	3	75.0%	0	5	5.0	-10	3	12	51.8%
11/3	HOU	L 110-102	21	9	2	2	0	2	0	4	1	25.0%	7	3	42.9%	11	4	36.4%	0	0	0.0%	1	1	0.0	-2	3	4	40.9%
11/1	DET	L 122-110	22	7	2	0	0	1	2	3	1	33.3%	2	2	100.0%	5	3	60.0%	0	0	0.0%	0	2	0.0	-21	1	6	70.0%
10/29	IND	W 107-105	22	3	2	2	0	0	1	1	0	0.0%	1	0	0.0%	2	0	0.0%	4	3	75.0%	0	2	2.0	+3	3	3	39.9%
10/27	OKC	L 101-94	23	9	4	0	0	1	0	2	0	0.0%	5	2	40.0%	7	2	28.6%	5	5	100.0%	1	3	0.0	-15	2	8	48.9%
10/26	TOR	W 139-129	24	12	6	3	0	2	2	0	0	0.0%	4	4	100.0%	4	4	100.0%	4	4	100.0%	1	5	1.5	+8	1	23	104.2%
10/24	WAS	L 117-107	25	7	6	4	0	2	1	1	0	0.0%	5	2	40.0%	6	2	33.3%	3	3	100.0%	1	5	4.0	-1	4	9	47.8%
10/22	SAS	L 125-92	22	3	1	1	0	0	0	0	0	0.0%	2	0	0.0%	2	0	0.0%	4	3	75.0%	0	1	0.0	-17	2	1	39.9%
Regular Season Totals			29.5	15.2	4.7	3.3	0.1	1.1	1.6	2.9	0.8	29.1%	8.2	4.8	58.7%	11.1	5.7	51.0%	4.1	3.1	76.0%	0.9	3.8	2.0	-218	1.9	19.0	59.2%

Naji Marshall: Breaking News

Marshall (hip) is listed as out for Sunday's game against Chicago. Marshall won't play in Sunday's contest against Chicago, marking his third consecutive absence and the end of his 2025-26 campaign. Without him, Klay Thompson and Khris Middleton are in line to see more minutes while receiving additional scoring opportunities.

Marshall (hip) is listed as doubtful for Sunday's regular-season finale against the Bulls. It appears as though Marshall will miss a third consecutive game while tending to a left hip contusion. If he's indeed ruled out for Sunday's game, he'll end the 2025-26 regular season averaging a career-high 15.2 points per game along with 4.7 rebounds, 3.3 assists, 1.1 steals and 0.8 threes over 29.5 minutes per game. Klay Thompson (rest), Khris Middleton and John Poulakidas should operate in elevated roles if Marshall is sidelined.

Marshall (hip) has been ruled out for Friday's game against the Spurs. As expected after entering the day with a doubtful tag, Marshall will sit out his second consecutive contest due to a left hip contusion he sustained during Tuesday's loss to the Clippers. With Marshall officially sidelined again, the Mavericks will likely lean on Khris Middleton and Tyler Smith to absorb the available minutes in the frontcourt.